LiqTech International (NASDAQ:LIQT – Free Report) had its price objective cut by Ascendiant Capital Markets from $5.15 to $3.20 in a research report sent to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock.
A number of other equities research analysts have also recently commented on LIQT. StockNews.com initiated coverage on shares of LiqTech International in a report on Wednesday, November 20th. They issued a “sell” rating for the company. Lake Street Capital reduced their price objective on LiqTech International from $9.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, October 10th.
Check Out Our Latest Stock Report on LiqTech International
LiqTech International Trading Up 6.0 %
Institutional Trading of LiqTech International
An institutional investor recently raised its position in LiqTech International stock. HighTower Advisors LLC increased its position in shares of LiqTech International, Inc. (NASDAQ:LIQT – Free Report) by 40.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,599 shares of the company’s stock after purchasing an additional 11,043 shares during the period. HighTower Advisors LLC owned approximately 0.66% of LiqTech International worth $99,000 as of its most recent SEC filing. Institutional investors own 35.06% of the company’s stock.
About LiqTech International
LiqTech International, Inc, a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company operates through Water, Ceramics, and Plastics segments.
Further Reading
- Five stocks we like better than LiqTech International
- 10 Best Airline Stocks to Buy
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Where Do I Find 52-Week Highs and Lows?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Manufacturing Stocks Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for LiqTech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiqTech International and related companies with MarketBeat.com's FREE daily email newsletter.